Regentis Biomaterials Ltd. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Regentis Biomaterials Ltd. (RGNT) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $7.04 million for the 12-month period ending 2025-12-31, per its 20-F/A filed 2026-02-27.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-02-27
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|
| 2025-12-31 | $7.04M 20-F/A · filed 2026-02-27 |